What are the major opportunities in the Urticaria market? What are the strategies for the Urticaria market?

For detailed insights on the major opportunities and strategies in the Urticaria market, Read More

How does the Urticaria market relate to the overall economy and other similar markets?

For detailed insights on Urticaria's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Urticaria market growth? SWOT analysis of the Urticaria market.

For detailed insights on the key dynamics influencing the Urticaria market growth and SWOT analysis of the Urticaria industry, Read More

Urticaria Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Urticaria Market Report 2026

Name: Urticaria Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Acute Urticaria, Chronic Urticaria), By Drug Class (Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Other Drug Classes), By Route of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Urticaria Market Overview

• Urticaria market size has reached to $4.76 billion in 2025

• Expected to grow to $10.71 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%

• Growth Driver: Rising Skin Disease Awareness Fueling Growth Of The Market Due To Greater Focus On Early Detection And Treatment

• Market Trend: Advancing Urticaria Treatment with Innovative Mast Cell Inhibitor Antibodies

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Urticaria Market?

Urticaria, commonly known as hives, is a skin condition characterized by red, itchy, and raised welts. It occurs due to an allergic reaction, stress, or unknown triggers, leading to histamine release. The condition can be acute (lasting less than six weeks) or chronic (persisting longer). Treatment includes antihistamines, avoiding triggers, and, in severe cases, corticosteroids or immunotherapy.

The main types of urticaria are acute urticaria and chronic urticaria. Acute urticaria is a sudden-onset skin condition lasting less than six weeks, characterized by red, itchy, and swollen welts, often triggered by allergic reactions, infections, medications, insect stings, or food allergens. This includes drug classes such as antihistamines, anti-inflammatory medications, antidepressants, monoclonal antibodies, and others, given by routes of administration such as oral, parenteral, and others. These are distributed by various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, to the end users consisting of hospitals, homecare, specialty clinics, and others.

Urticaria Market Global Report 2026 Market Report bar graph

What Is The Urticaria Market Size and Share 2026?

The urticaria market size has grown rapidly in recent years. It will grow from $4.76 billion in 2025 to $5.61 billion in 2026 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to increasing prevalence of allergic skin conditions, wider use of antihistamines, expansion of dermatology treatment services, rising awareness of chronic urticaria, availability of prescription therapies.

What Is The Urticaria Market Growth Forecast?

The urticaria market size is expected to see rapid growth in the next few years. It will grow to $10.71 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing adoption of biologic treatments, rising demand for long-acting therapies, growing focus on immune-modulating drugs, expansion of specialty dermatology clinics, increasing investment in allergy and immunology research. Major trends in the forecast period include increasing development of biologic and monoclonal antibody therapies, growing use of personalized treatment approaches, rising focus on chronic urticaria management, expansion of advanced antihistamine formulations, enhanced emphasis on long-term disease control.

Book your 30 minutes free consultation with our research experts

Global Urticaria Market Segmentation

1) By Type: Acute Urticaria, Chronic Urticaria

2) By Drug Class: Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Other Drug Classes

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Urticaria: Allergic Urticaria, Infectious Urticaria, Drug-Induced Urticaria, Contact Urticaria

2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU)

What Is The Driver Of The Urticaria Market?

The increasing skin disease awareness and treatment is expected to boost the growth of the urticaria market going forward. Increasing pollution leads to more skin allergies and conditions, driving demand for awareness and advanced treatments. Urticaria contributes to skin disease awareness and treatment by showcasing immune system responses, driving research, enhancing diagnostics, and advancing targeted therapies. For instance, in February 2024, The Skin Cancer Foundation, a US-based nonprofit, reported that 1 in 5 Americans develop skin cancer by age 70, with over 2 deaths occurring every hour in the U.S. This highlights the urgent need for preventive measures, as having five or more sunburns doubles the risk of melanoma. Therefore, increasing skin disease awareness and treatment is driving the growth of the urticaria industry.

Key Players In The Global Urticaria Market

Major companies operating in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma

Global Urticaria Market Trends and Insights

Major companies operating in the urticaria market are focusing on developing innovative solutions such as mast cell inhibitor antibodies to develop an advanced therapeutic solution for managing chronic spontaneous urticaria by targeting mast cell activation. A mast cell inhibitor antibody is a targeted monoclonal antibody that blocks the activation or degranulation of mast cells by inhibiting specific receptors or signaling pathways, thereby reducing allergic reactions, inflammation, and other mast cell-mediated disorders. For instance, in May 2024, Allakos Inc., a US-based biotechnology company, announced the initiation of a Phase 1 clinical trial for AK006, designed for the treatment of chronic spontaneous urticaria (CSU). This innovative therapy targets both IgE-dependent and IgE-independent mast cell activation pathways, offering the potential for broader efficacy in patients who are refractory to antihistamines or prior biologic treatments. By selectively inhibiting mast cell activity through the Siglec-6 receptor, AK006 aims to provide a more comprehensive and long-lasting solution for CSU management, marking a significant advancement in urticaria treatment and immunotherapy research.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Urticaria Market?

In April 2024, Incyte Corporation, a US-based biopharmaceutical company, acquired Escient Pharmaceuticals for $750 million. This deal aims to strengthen Incyte Corporation’s portfolio in inflammation and autoimmunity (IAI) by advancing first-in-class oral Mas-related G protein-coupled receptor X2 (MRGPRX2) and Mas-related G protein-coupled receptor X4 (MRGPRX4) antagonists, which have the potential to enhance treatments for chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), atopic dermatitis (AD), cholestatic pruritus, and other inflammatory disorders. Escient Pharmaceuticals is a US-based clinical-stage biotechnology company focused on developing small-molecule therapies for chronic urticaria and severe pruritus.

Regional Outlook

North America was the largest region in the urticaria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Urticaria Market?

The urticaria market consists of sales of corticosteroids, biologics, immunosuppressants, leukotriene receptor antagonists, and topical anti-inflammatory creams or gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Urticaria Market Report 2026?

The urticaria market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the urticaria industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Urticaria Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.61 billion
Revenue Forecast In 2035	$10.71 billion
Growth Rate	CAGR of 17.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Drug Class, Route of Administration, Distribution Channel, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Urticaria Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Urticaria Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Urticaria Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Urticaria Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Development Of Biologic And Monoclonal Antibody Therapies

4.2.2 Growing Use Of Personalized Treatment Approaches

4.2.3 Rising Focus On Chronic Urticaria Management

4.2.4 Expansion Of Advanced Antihistamine Formulations

4.2.5 Enhanced Emphasis On Long-Term Disease Control

5. Urticaria Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Dermatology Clinics

5.4 Homecare Providers

5.5 Retail Pharmacies

6. Urticaria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Urticaria Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Urticaria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Urticaria Market Size, Comparisons And Growth Rate Analysis

7.3. Global Urticaria Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Urticaria Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Urticaria Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Urticaria Market Segmentation

9.1. Global Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Urticaria, Chronic Urticaria

9.2. Global Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Other Drug Classes

9.3. Global Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Routes Of Administration

9.4. Global Urticaria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

9.5. Global Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End-Users

9.6. Global Urticaria Market, Sub-Segmentation Of Acute Urticaria, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Allergic Urticaria, Infectious Urticaria, Drug-Induced Urticaria, Contact Urticaria

9.7. Global Urticaria Market, Sub-Segmentation Of Chronic Urticaria, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU)

10. Urticaria Market Regional And Country Analysis

10.1. Global Urticaria Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Urticaria Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Urticaria Market

11.1. Asia-Pacific Urticaria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Urticaria Market

12.1. China Urticaria Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Urticaria Market

13.1. India Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Urticaria Market

14.1. Japan Urticaria Market Overview

14.2. Japan Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Urticaria Market

15.1. Australia Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Urticaria Market

16.1. Indonesia Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Urticaria Market

17.1. South Korea Urticaria Market Overview

17.2. South Korea Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Urticaria Market

18.1. Taiwan Urticaria Market Overview

18.2. Taiwan Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Urticaria Market

19.1. South East Asia Urticaria Market Overview

19.2. South East Asia Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Urticaria Market

20.1. Western Europe Urticaria Market Overview

20.2. Western Europe Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Urticaria Market

21.1. UK Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Urticaria Market

22.1. Germany Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Urticaria Market

23.1. France Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Urticaria Market

24.1. Italy Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Urticaria Market

25.1. Spain Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Urticaria Market

26.1. Eastern Europe Urticaria Market Overview

26.2. Eastern Europe Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Urticaria Market

27.1. Russia Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Urticaria Market

28.1. North America Urticaria Market Overview

28.2. North America Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Urticaria Market

29.1. USA Urticaria Market Overview

29.2. USA Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Urticaria Market

30.1. Canada Urticaria Market Overview

30.2. Canada Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Urticaria Market

31.1. South America Urticaria Market Overview

31.2. South America Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Urticaria Market

32.1. Brazil Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Urticaria Market

33.1. Middle East Urticaria Market Overview

33.2. Middle East Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Urticaria Market

34.1. Africa Urticaria Market Overview

34.2. Africa Urticaria Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Urticaria Market Regulatory and Investment Landscape

36. Urticaria Market Competitive Landscape And Company Profiles

36.1. Urticaria Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Urticaria Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Urticaria Market Company Profiles

36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Urticaria Market Other Major And Innovative Companies

Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma

38. Global Urticaria Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Urticaria Market

40. Urticaria Market High Potential Countries, Segments and Strategies

40.1 Urticaria Market In 2030 - Countries Offering Most New Opportunities

40.2 Urticaria Market In 2030 - Segments Offering Most New Opportunities

40.3 Urticaria Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Urticaria Market, Overview Of Key Products - Product Examples

Table 2: Global Urticaria Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Urticaria Market, Supply Chain Analysis

Table 4: Global Urticaria Market, Major Raw Material Providers

Table 5: Global Urticaria Market, Major Resource Providers

Table 6: Global Urticaria Market, Major Manufacturers (Suppliers)

Table 7: Global Urticaria Market, Major Distributors And Channel Partners

Table 8: Global Urticaria Market, Key Technologies & Future Trends

Table 9: Global Urticaria Market, Major Trends

Table 10: Global Urticaria Market, Major End Users

Table 11: Global Urticaria Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Urticaria Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Urticaria Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Urticaria Market - TAM, US$ Billion, 2025

Table 15: Global Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Urticaria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Urticaria Market, Sub-Segmentation Of Acute Urticaria, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Urticaria Market, Sub-Segmentation Of Chronic Urticaria, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Urticaria Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Urticaria Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Urticaria Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Urticaria Market - Company Scoring Matrix

Table 98: Sanofi S.A. Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: GlaxoSmithKline PLC Financial Performance

Table 101: Roche Holding AG Financial Performance

Table 102: Teva Pharmaceutical Industries Ltd Financial Performance

Table 103: Global Urticaria Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Urticaria Market, Competitive Dashboard

Table 105: Global Urticaria Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Urticaria Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Urticaria Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 108: Global, Urticaria Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Urticaria Market, Overview Of Key Products - Product Examples

Figure 2: Global Urticaria Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Urticaria Market, Supply Chain Analysis

Figure 4: Global Urticaria Market, Major Raw Material Providers

Figure 5: Global Urticaria Market, Major Resource Providers

Figure 6: Global Urticaria Market, Major Manufacturers (Suppliers)

Figure 7: Global Urticaria Market, Major Distributors And Channel Partners

Figure 8: Global Urticaria Market, Key Technologies & Future Trends

Figure 9: Global Urticaria Market, Major Trends

Figure 10: Global Urticaria Market, Major End Users

Figure 11: Global Urticaria Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Urticaria Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Urticaria Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Urticaria Market - TAM, US$ Billion, 2025

Figure 15: Global Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Urticaria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Urticaria Market, Sub-Segmentation Of Acute Urticaria, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Urticaria Market, Sub-Segmentation Of Chronic Urticaria, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Urticaria Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Urticaria Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Urticaria Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Urticaria Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Urticaria Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Urticaria Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Urticaria Market - Company Scoring Matrix

Figure 98: Sanofi S.A. Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: GlaxoSmithKline PLC Financial Performance

Figure 101: Roche Holding AG Financial Performance

Figure 102: Teva Pharmaceutical Industries Ltd Financial Performance

Figure 103: Global Urticaria Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Urticaria Market, Competitive Dashboard

Figure 105: Global Urticaria Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Urticaria Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Urticaria Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 108: Global, Urticaria Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors), By Distribution...

Ursolic Acid Market Report 2026 - Global Outlook – By Form (Powdered Form, Capsules, Liquid Form), By Type (25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Other Types), By End-Use (Pharmaceutical...

Allergic Rhinitis Market Report 2026 - Global Outlook – By Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Dec...

Urea Market Report 2026 - Global Outlook – By Grade (Fertilizer Grade, Feed Grade, Technical Grade), By Technology (Stamicarbon Technology, SnamProgetti Or Saipem Technology, Conventional Technologies, Other Technologies...

Atopic Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Other Drug Classes), By Mode of Administration (Topica...

Psoriasis Market Report 2026 - Global Outlook – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor), By Drug Types (Small molecules, Biologics ), By Disease Indica...

Allergic Rhinitis Drugs Market Report 2026 - Global Outlook – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticoster...

Frequently Asked Questions

How big is the Urticaria Market?

The Urticaria market was valued at $4.76 billion in 2025, increased to $5.61 billion in 2026, and is projected to reach $10.71 billion by 2030.

What is the Urticaria market growth?

The global Urticaria market is expected to grow at a CAGR of 17.5% from 2026 to 2035 to reach $10.71 billion by 2035.

Who are the key players in Urticaria market?

Some Key Players in the Urticaria market Include, Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma .

What is the anticipated growth trend for the Urticaria market?

Major trend in this market includes: Advancing Urticaria Treatment with Innovative Mast Cell Inhibitor Antibodies. For further insights on this market. request a sample here

Which region has the most growth potential in the Urticaria market?

North America was the largest region in the urticaria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urticaria market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.